Rabeprazole Sodium Enteric?Coated Tablets 20?mg × 28 Capsules (Shiyao / Oujiaan)

Rabeprazole Sodium Enteric?Coated Tablets 20?mg × 28 Capsules (Shiyao / Oujiaan)

$3.00

Rabeprazole Sodium Enteric?Coated Capsules (brand: Shiyao / Oujiaan) deliver 20?mg of rabeprazole sodium per capsule, 28 capsules per box. Manufactured by Shiyao Group Ouyi Pharmaceutical Co., Ltd., and approved under NMPA registration H20233808. A proton pump inhibitor (PPI) ideal for laboratory research in acid suppression, gastrointestinal physiology models, pharmacokinetics, and enteric coating formulation studies.?? Strictly for laboratory research use only. ?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans

Description

Rabeprazole Sodium Enteric Product Specifications

SpecificationDescription
Product NameRabeprazole Sodium Enteric?Coated Tablets (Shiyao / Oujiaan)
Generic NameRabeprazole Sodium
CAS Number117976?90?6
Molecular FormulaC??H??N?NaO?S
Molecular Weight381.42?g/mol
FormulationEnteric?coated capsule
Strength20?mg per capsule
Pack Size28 capsules per box
Approval NumberH20233808 (NMPA, China)
Product Code86902770004717
ManufacturerShiyao Group Ouyi Pharmaceutical Co., Ltd.
Barcode6916119043521
Storage ConditionsStore below 30?°C in a dry, ventilated place, protected from light
Intended UseFor laboratory research only

Rabeprazole Sodium Enteric Mechanism of Action

Rabeprazole is a proton pump inhibitor that irreversibly binds to and inactivates the H?/K??ATPase enzyme in gastric parietal cells, significantly reducing stomach acid secretion for up to 24 hours chemspider.com+15en.wikipedia.org+15sciencedirect.com+15. Its enteric coating protects stability in stomach acid and enables absorption in the intestine .


Rabeprazole Sodium Enteric Research Applications & Pharmacology

  • Gastrointestinal acid suppression models: used in GERD, peptic ulcer, Zollinger–Ellison syndrome research

  • PK/PD studies: evaluation of delayed-release tablets and absorption kinetics

  • Enteric?coating formulation research: ideal for studying stability and release in simulated gastric/intestinal conditions

  • Drug interaction assays: rabeprazole is metabolized via CYP2C19 and CYP3A4, useful for hepatic clearance studies


Safety Profile & Handling

  • Preclinical safety: generally well tolerated; common side effects include mild GI discomfort and headache

  • Handling: lab PPE recommended—gloves, mask, coat; avoid inhalation of powder

  • Storage: store in cool, dry, light-protected conditions

  • Disposal: follow institutional chemical waste protocols


Core Keywords

rabeprazole sodium, PPI research, CAS 117976?90?6, enteric-coated rabeprazole, gastric acid inhibitor, laboratory rabeprazole, wholesale rabeprazole, Shiyao Oujiaan


Research?Use Disclaimer

This product is intended only for laboratory research purposes. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. Misuse may pose health risks. Always adhere to institutional safety and biosafety protocols.

Additional information

Weight1 kg
Dimensions28 × 26 × 28 cm

Reviews

There are no reviews yet.

Be the first to review “Rabeprazole Sodium Enteric?Coated Tablets 20?mg × 28 Capsules (Shiyao / Oujiaan)”

Your email address will not be published. Required fields are marked *

EMI Options